Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) - and vascular endothelial growth factor-mediated cellular invasion and tumor growth

Cancer Research

Volumn 65, Issue 1, 2005, Pages 195-202

  Christine, Rivat ^a   Sylvie, Rodrigues ^a   Erik, Bruyneel ^b   Geneviève, Piétu ^c   Amélie, Robert ^c   Gérard, Redeuilh ^a   Marc, Bracke ^a   Christian, Gespach ^a   Samir, Attoub ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CUCURBITACIN GLYCOSIDE; GENE PRODUCT; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; NEUROPILIN 1; NEUROPILIN 2; PROTEIN INHIBITOR; PROTEIN STAT3ALPHA; PROTEIN STAT3BETA; STAT3 INHIBITORY PEPTIDE; STAT3 PROTEIN; TREFOIL FACTOR 1; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CELL INVASION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA BINDING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NUDE MOUSE; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT;

APOPTOSIS; BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; KINETICS; MUCINS; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; PEPTIDES; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 11244255857     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bishop J. Cellular oncogenes and retroviruses. Annu Rev Biochem 1983;52:301-54.
2. Di Renzo MF, Olivero M, Giacomini A, et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995;1:147-54.
3. Irby RB, Yeatman TJ. Role of src expression and activation in human cancer. Oncogene 2000;19:5636-42.
4. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130-4.
5. Attoub S, Noe V, Pirola L, et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 2000;14:2329-38.
6. Attoub S, Rivat C, Rodrigues S, et al. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. Cancer Res 2002;62:4879-83.
7. Pasche B. Role of transforming growth factor β in cancer. J Cell Physiol 2001;186:153-68.
8. Radinsky R, Risin, Fan, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995;1:19-31.
9. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000;19:5598-605.
10. Podolsky DK. Mechanisms of regulatory peptide action in the gastrointestinal tract: trefoil peptides. J Gastroenterol 2000;35 Suppl 12:69-74.
11. Emami S, Rodrigues S, Rodrigue CM, et al. Trefoil factor family (TFF) peptides and cancer progression. Peptides 2004;25:885-98.
12. Rodrigues S, Attoub S, Nguyen QD, et al. Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Oncogene 2003;22:4488-97.
13. Emami S, Le Floch N, Bruyneel E, et al. Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA- transformed kidney and colonic epithelial cells. FASEB J 2001;15:351-61.
14. Boccaccio C, Ando M, Tamagnone L, et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998;391:285-8.
15. Goiot H, Attoub S, Kermorgant S, et al. Antral mucosa expresses functional leptin receptors coupled to STAT-3 signaling, which is involved in the control of gastric secretions in the rat. Gastroenterology 2001;121:1417-27.
16. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL. Regulation of STAT3 by direct binding to the Racl GTPase. Science 2000;290:144-7.
17. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R. Stat3 activation by src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 1998;18:2545-52.
18. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000;19:2474-88.
19. Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol 2004;10:1569-73.
20. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999;98:295-303.
21. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A 2001;98:1543-8.
22. Niu G, Wright KL, Huang M, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002;21:2000-8.
23. Bartoli M, Platt D, Lemtalsi T, et al. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 2003;17:1562-4.
24. Caldenhoven E, van Dijk TB, Solari R, et al. STAT3β a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 1996;271:13221-7.
25. Garcia R, Bowman TL, Niu G, et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001;20:2499-513.
26. Niu G, Heller R, Catlett-Falcone R, et al. Gene therapy with dominant-negative Stat3 suppresses growth of the nuirine melanoma B16 tumor in vivo. Cancer Res 1999;59:5059-63.
27. Vermeulen SJ, Bruynecl EA, Bracke ME, et al. Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells. Cancer Res 1995;55:4722-8.
28. Soares MB, Bonaldo MF, Jelene P, Su L, Lawton L, Efstratiadis A. Construction and characterization of a normalized cDNA library. Proc Natl Acad Sci U S A 1994;91:9228-32.
29. Auffray C, Behar G, Bois F, et al. IMAGE: molecular integration of the analysis of the human genome and its expression. C R Acad Sci III 1995;318:263-72.
30. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003;63:1270-9.
31. Turkson J, Ryan D, Kim JS, et al. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001;276:45443-55.
32. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 2002;12:13-9.
33. Fuh G, Garcia KC, de Vos AM. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-L. J Biol Chem 2000;275:26690-5.
34. Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem 2001;276:18688-94.
35. Andre T, Kotelevets L, Vaillant JC, et al. Vegf, Vegf-B. Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neroplastic progression of human colonic mucosa. Int J Cancer 2000;86:174-81.
36. Tebbutt NC, Giraud AS, Inglese M, et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002;8:1089-97.
37. Schaefer TS, Sanders LK, Park OK, Nathans D. Functional differences between Stat3α and Stat3β. Mol Cell Biol 1997;17:5307-16.
38. Rockman SP, Currie SA, Ciavarella M, et al. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 2001;276:45113-9.
39. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59.
40. Norton JD, ID helix-loop-helix proteins in cell growth. differentiation and tumorigenesis. J Cell Sci 2000;113:3897-905.